The firm’s syrup has currently owner of wockhardt pharma come under scrutiny concerning reports of contamination substances . This specific product was first distributed for addressing multiple cough issues. An probe is in progress to identify the extent of the problem and verify the wellbeing of patients . More data are anticipated to emerge as